Erythropoietin therapy in children with bronchiolitis and anemia

Pediatric Critical Care Medicine

Volumn 4, Issue 1, 2003, Pages 44-48

  Jacobs, Brian R ^a   Lyons, Kim ^a   Brilli, Richard J ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anemia; Bronchiolitis; Children; Critical care; Erythropoietin; Pediatric; Transfusion

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BRONCHIOLITIS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; INFANT; MALE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ANEMIA; BLOOD TRANSFUSION; BRONCHIOLITIS; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; ERYTHROPOIETIN; FEMALE; HUMANS; INFANT; MALE; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 85047688055     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/00130478-200301000-00008     Document Type: Conference Paper

References (34)

1. Kim HW, Arrobio JO, Brandt CD, et al: Epidemiology of respiratory syncytial virus infection in Washington D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973; 98:216-225
2. Clarke SKR, Gardner PS, Poole PM, et al: Respiratory syncytial virus infection: Admissions to hospital in industrial, urban, and rural areas. BMJ 1978; 2:796-798
3. Meert KL, Sarnaik AP, Gelmini MJ, et al: Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind randomized trial. Crit Care Med 1994; 22:566-572
4. Smith DW, Frankel LR, Mathers LH, et al: A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991; 325:24-29
5. Venkataraman ST, Orr RA: Mechanical ventilation and respiratory care. In: Pediatric Critical Care. Fuhrman BP, Zimmerman JJ (Eds). St. Louis, MO, Mosby Year Book, 1992, pp 519-543
6. Erslev AJ. Erythropoietin. N Engl J Med 1991; 324:1339-1344
7. Erslev AJ, Caro J, Miller O, et al: Plasma erythropoietin in health and disease. Ann Clin Lab Sci 1980; 10:250-257
8. Chandra M, McVicar M, Clemmons G, et al: Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis. Nephron 1987; 46: 312-315
9. Varan A, Büyükpamukçu M, Kutluk T, et al: Recombinant human erythropoietin treatment for chemotherapy-related anemia in children. Pediatrics 1999; 103:1-4
10. Maier RF, Obladen M, Scigalla P, et al: The effect of epoetin beta (recombinant erythropoietin) on the need for transfusion in verylow- birth-weight infants. N Engl J Med 1994; 330:1173-1178
11. Fischl M, Galpin JE, Levine JD, et al: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322:1488-1493
12. Aoki I, Higashi K, Homori M, et al: Responsiveness of bone marrow erythropoietin stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-EP) in vitro in aplastic anemia and myelodysplastic syndrome. Am J Hematol 1990; 35:6-12
13. Rodgers GP, Dover GJ, Uyesaka N, et al: Augmentation by erythropoietin of the fetal hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993; 328:73-80
14. Krafte-Jacobs B, Levetown ML, Bray GL, et al: Erythropoietin response to critical illness. Crit Care Med 1994; 22:821-826
15. Corwin HL, Gettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350
16. Meyer MP, Meyer JH, Commerford A, et al: Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994; 93:918-923
17. Ohls RK, Christensen RD: Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991; 119:781-788
18. Messer J, Haddad J, Donato L, et al: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993; 92:519-523
19. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
20. Krafte-Jacobs B, Williams J, Soldin SJ: Plasma erythropoietin reference ranges in children. J Pediatr 1995; 126:601-603
21. Welliver R, Cherry JD: Bronchiolitis and infectious asthma. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD (Eds). Philadelphia, Saunders, 1987, pp 278-288
22. Parrott RH, Kim HW, Arrobio JO, et al: Epidemiology of respiratory syncytial virus infection in Washington D.C. II. Infection and disease with respect to age, immunologic status, race, and sex. Am J Epidemiol 1973; 98:289-300
23. Cumming PD, Wallace EL, Schorr JB, et al: Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N Engl J Med 1989; 321:941
24. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341:1227-1232
25. Alexander SR: Pediatric uses of recombinant human erythropoietin: The outlook in 1991. Am J Kid Dis 1991; 18:42-53
26. Eschbach JW, Egrie JC, Downing MR, et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 316:2:73-78
27. Shannon KM, Keith JF, Mentzer WC, et al: Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95:1-8
28. Porter JC, Leahey A, Polise K, et al: Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial. J Pediatr 1996; 129:656-660
29. Shimpo H, Mizumoto T, Onoda K, et al: Erythropoietin in pediatric cardiac surgery: Clinical efficacy and effective dose. Chest 1997; 111:1565-1570
30. Levine EA, Rosen AL, Schgal LR, et al: Treatment of acute postoperative anemia with recombinant human erythropoietin. J Trauma 1989; 29:1134-1138
31. McMahon FG, Vargas R, Ryan M, et al: Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 9:1718-1722
32. Van Schaik SM, Welliver RC, Kimpen JLL: Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatr Pulmonol 2000; 30:131-138
33. Schreiber S, Howaldt S, Schnoot M, et al: Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334:619-623
34. Gabriel A, Kozek S, Chiari A, et al: High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998; 44:361-367